← Every company
CRISPR Therapeutics AG SEC Filings
What CRISPR Therapeutics AG has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
CRSP overview →Filings on file
125
since Oct 19, 2016
Warning signs
0
none filed
Last results
Aug 3, 2026
8-K item 2.02
Industry
Biological Products, (No Diagnostic Substances)
SIC 2836
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| Jun 4, 2026 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Mar 26, 2025 | Executive or director change 8-K | Read ↗ |
| Jun 3, 2024 | Executive or director changeShareholder vote 8-K | Read ↗ |
| May 23, 2024 | Executive or director change 8-K | Read ↗ |
| Dec 19, 2023 | Executive or director change 8-K | Read ↗ |
| Sep 7, 2023 | Executive or director change 8-K | Read ↗ |
| Jun 9, 2023 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Mar 29, 2023 | Executive or director change 8-K | Read ↗ |
| Mar 14, 2023 | Executive or director change 8-K | Read ↗ |
| Oct 27, 2022 | Executive or director change 8-K | Read ↗ |
| Jun 13, 2022 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Dec 20, 2021 | Executive or director change 8-K | Read ↗ |
| Oct 14, 2021 | Executive or director change 8-K | Read ↗ |
| Jun 12, 2020 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Feb 26, 2020 | Executive or director change 8-K | Read ↗ |
| Jan 29, 2020 | Executive or director change 8-K | Read ↗ |
| Dec 27, 2019 | Executive or director changeMaterial agreement 8-K | Read ↗ |
| Jun 13, 2019 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Jun 1, 2018 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Dec 21, 2017 | Executive or director change 8-K | Read ↗ |
| Nov 13, 2017 | Executive or director change 8-K | Read ↗ |
| Oct 2, 2017 | Executive or director change 8-K | Read ↗ |
| Jul 27, 2017 | Executive or director change 8-K | Read ↗ |
| Jun 2, 2017 | Executive or director changeShareholder vote 8-K | Read ↗ |
| May 4, 2017 | Executive or director change 8-K | Read ↗ |
| Mar 20, 2017 | Executive or director change 8-K | Read ↗ |
Source: CRISPR Therapeutics AG's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.
More on CRSP
Company overviewEverything on CRSP in one place, with the price.Insider tradingWhat CRSP's own officers and directors buy and sell.Planned salesSales CRSP insiders have filed notice of.Executive payWhat CRSP awarded its chief executive, and what it became.LobbyingWhat CRSP spends lobbying Congress, and on what.PatentsWhat CRSP is filing at the patent office.